| Patient | Wolfgang Amadeus Mozart |
|---|---|
| Date of birth | 1998-01-27 |
| Identifiers | MRN HR-EN009-SYN; SSN (made up) 000-09-3517 |
| Document date | 2026-11-01 |
| Author | Theodora Kranzler-Obi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for swelling of the face and legs and dark urine after a sore throat: urgent kidney and streptococcal tests, treatment of fluid overload and the infection, and an urgent nephrology referral. Concerns: He is afraid his kidneys will be damaged for good; He loses income for every concert and lesson he misses. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Penicillin V potassium 500 mg tablet, one tablet by mouth twice a day for ten days | twice a day for 10 days | Oral route | 2026-09-15 to 2026-09-25 | completed | S |
| Furosemide 40 mg tablet, one tablet by mouth each morning while swollen | once each morning | Oral route | 2026-09-15 to 2026-09-29 | stopped | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Rapid antigen test for group A streptococcus on a throat swab | 2026-09-15 to 2026-09-15 | completed | S |
| Twelve-lead electrocardiogram | 2026-09-17 to 2026-09-17 | completed | S |
| Transthoracic echocardiogram with Doppler | 2026-09-17 to 2026-09-17 | completed | S |
| Advance care planning conversation, about 16 minutes | 2026-10-13 to 2026-10-13 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-10-13 | Tdap vaccine | completed | S |
| 2026-10-13 | Influenza vaccine, 2026-2027 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| late 1762 | Scarlet fever at about six, with two weeks in bed | D (CLM-0002) |
| autumn 1765 | A violent fever at nine that left him very weak for several weeks | D (CLM-0003) |
| 1767 | Smallpox at eleven, severe, with nine days of blindness; recovered with no lasting eye problem recorded | D (CLM-0004) |
| spring 1783 | An acute illness described as cholera, during an epidemic, at 27 | D (CLM-0005) |
| before 1784 | Frequent sore throats (tonsillitis) through life, a retrospective interpretation | R (CLM-0015) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died while traveling abroad after an illness of some weeks; cause not recorded in the cited source | D (CLM-0008) | |
| sibling | Five of the seven children of his parents died young; causes not recorded in the cited source | D (CLM-0001) |
| Concern | Status | Evidence |
|---|---|---|
| He is afraid his kidneys will be damaged for good | active | S |
| He loses income for every concert and lesson he misses | active | S |
Most recent measures: Sodium [Moles/volume] in Serum or Plasma 136 on 2026-09-15; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-10-27; Urea nitrogen [Mass/volume] in Serum or Plasma 18 on 2026-09-29; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 2026-10-27; Albumin [Mass/volume] in Serum or Plasma 3.6 on 2026-09-15; Hemoglobin [Mass/volume] in Blood 13.4 on 2026-09-15; Leukocytes [#/volume] in Blood by Automated count 8.9 on 2026-09-15; Platelets [#/volume] in Blood by Automated count 265 on 2026-09-15; C reactive protein [Mass/volume] in Serum or Plasma 18 on 2026-09-15; Erythrocyte [Sedimentation Rate] in Blood by Westergren method 38 on 2026-09-15; Complement C3 [Mass/volume] in Serum or Plasma 108 on 2026-10-27; Complement C4 [Mass/volume] in Serum or Plasma 24 on 2026-09-15; Streptolysin O Ab [Units/volume] in Serum or Plasma 620 on 2026-09-15; Streptococcal DNAse B [Units/volume] in Serum 980 on 2026-09-15; Erythrocytes [#/area] in Urine sediment by Microscopy high power field 12 on 2026-10-22; Protein/Creatinine [Mass Ratio] in Urine 180 on 2026-10-27; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 116 on 2026-10-27; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-13; Total score [AUDIT-C] 2 on 2026-09-15; P-R Interval 156 on 2026-09-17; Left ventricular Ejection fraction 62 on 2026-09-17 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Swelling of the face and legs with cola-colored urine, less urine, raised blood pressure, and reduced kidney function (acute nephritic picture), two to three weeks after a febrile sore throat and followed by aching knees and ankles, crampy abdominal pain, and vomiting; cause not yet confirmed at intake; urgent nephrology consultation requested | resolved | confirmed | R60.1 | S — Synthetic presenting problem anchored to his documented febrile illness of 1784; superseded by the diagnosis at the nephrology consultation. |
| Group A streptococcal pharyngitis, rapid antigen test positive at intake with a mildly red throat two to three weeks after the sore throat began; penicillin V started | resolved | confirmed | J02.0 | S — Synthetic modern infection that triggers the episode; his recurrent sore throats are a retrospective interpretation (CLM-0015). |
| Acute post-streptococcal glomerulonephritis: acute nephritic syndrome with red cell casts, hypertension, edema, and a rise in creatinine, low C3 with normal C4, and raised ASO and anti-DNase B after group A streptococcal pharyngitis; no kidney biopsy, because the course is typical; acute rheumatic fever excluded by the Jones criteria and a normal echocardiogram; synthetic modern episode linked to his documented illness of 1784 | active | confirmed | N00.9 | S — Synthetic modern diagnosis made at the nephrology consultation; it makes no claim about his real illnesses or the cause of his death. |
| Acute viral upper respiratory infection (common cold) with cough and runny nose four weeks after post-streptococcal glomerulonephritis; no strep test because the features were viral; urine unchanged; resolved | resolved | confirmed | J06.9 | S — Synthetic acute problem; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-09-15 | Potassium [Moles/volume] in Serum or Plasma | 4.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-09-15 | Urea nitrogen [Mass/volume] in Serum or Plasma | 31 | mg/dL | 6-24 mg/dL | High | S |
| 2026-09-15 | Creatinine [Mass/volume] in Serum or Plasma | 1.62 | mg/dL | 0.74-1.35 mg/dL | High | S |
| 2026-09-15 | Albumin [Mass/volume] in Serum or Plasma | 3.6 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-09-15 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-09-15 | Leukocytes [#/volume] in Blood by Automated count | 8.9 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 2026-09-15 | Platelets [#/volume] in Blood by Automated count | 265 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 2026-09-15 | C reactive protein [Mass/volume] in Serum or Plasma | 18 | mg/L | <=8 mg/L | High | S |
| 2026-09-15 | Erythrocyte [Sedimentation Rate] in Blood by Westergren method | 38 | mm/h | <=15 mm/h | High | S |
| 2026-09-15 | Complement C3 [Mass/volume] in Serum or Plasma | 42 | mg/dL | 90-180 mg/dL | Low | S |
| 2026-09-15 | Complement C4 [Mass/volume] in Serum or Plasma | 24 | mg/dL | 10-40 mg/dL | Normal | S |
| 2026-09-15 | Streptolysin O Ab [Units/volume] in Serum or Plasma | 620 | [IU]/mL | <=200 [IU]/mL | High | S |
| 2026-09-15 | Streptococcal DNAse B [Units/volume] in Serum | 980 | [IU]/mL | <=240 [IU]/mL | High | S |
| 2026-09-15 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 60 | /[HPF] | <=2 /[HPF] | High | S |
| 2026-09-15 | Protein/Creatinine [Mass Ratio] in Urine | 1400 | mg/g | <=150 mg/g | High | S |
| 2026-09-15 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 59 | mL/min/{1.73_m2} | 60 or more | Low | S |
| 2026-09-15 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-09-15 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 2026-09-17 | Potassium [Moles/volume] in Serum or Plasma | 5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-09-17 | Urea nitrogen [Mass/volume] in Serum or Plasma | 34 | mg/dL | 6-24 mg/dL | High | S |
| 2026-09-17 | Creatinine [Mass/volume] in Serum or Plasma | 1.78 | mg/dL | 0.74-1.35 mg/dL | High | S |
| 2026-09-17 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 45 | /[HPF] | <=2 /[HPF] | High | S |
| 2026-09-17 | Protein/Creatinine [Mass Ratio] in Urine | 1100 | mg/g | <=150 mg/g | High | S |
| 2026-09-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 53 | mL/min/{1.73_m2} | 60 or more | Low | S |
| 2026-09-17 | P-R Interval | 156 | ms | 120-200 ms | Normal | S |
| 2026-09-17 | Left ventricular Ejection fraction | 62 | % | 52-74% | Normal | S |
| 2026-09-29 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-09-29 | Urea nitrogen [Mass/volume] in Serum or Plasma | 18 | mg/dL | 6-24 mg/dL | Normal | S |
| 2026-09-29 | Creatinine [Mass/volume] in Serum or Plasma | 1.05 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-09-29 | Complement C3 [Mass/volume] in Serum or Plasma | 74 | mg/dL | 90-180 mg/dL | Low | S |
| 2026-09-29 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 25 | /[HPF] | <=2 /[HPF] | High | S |
| 2026-09-29 | Protein/Creatinine [Mass Ratio] in Urine | 420 | mg/g | <=150 mg/g | High | S |
| 2026-09-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 99 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-10-27 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-10-27 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-10-27 | Complement C3 [Mass/volume] in Serum or Plasma | 108 | mg/dL | 90-180 mg/dL | Normal | S |
| 2026-10-27 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 8 | /[HPF] | <=2 /[HPF] | High | S |
| 2026-10-27 | Protein/Creatinine [Mass Ratio] in Urine | 180 | mg/g | <=150 mg/g | High | S |
| 2026-10-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 116 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-10-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-22 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 12 | /[HPF] | <=2 /[HPF] | High | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-15 | Body height | 163 | cm | S |
| 2026-09-15 | Body weight | 64.2 | kg | S |
| 2026-09-15 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 2026-09-15 | Systolic blood pressure | 162 | mm[Hg] | S |
| 2026-09-15 | Diastolic blood pressure | 100 | mm[Hg] | S |
| 2026-09-15 | Heart rate | 88 | /min | S |
| 2026-09-15 | Respiratory rate | 18 | /min | S |
| 2026-09-15 | Body temperature | 37.6 | Cel | S |
| 2026-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-09-17 | Body height | 163 | cm | S |
| 2026-09-17 | Body weight | 63 | kg | S |
| 2026-09-17 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 2026-09-17 | Systolic blood pressure | 148 | mm[Hg] | S |
| 2026-09-17 | Diastolic blood pressure | 94 | mm[Hg] | S |
| 2026-09-17 | Heart rate | 84 | /min | S |
| 2026-09-17 | Respiratory rate | 16 | /min | S |
| 2026-09-17 | Body temperature | 37.1 | Cel | S |
| 2026-09-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-09-29 | Body height | 163 | cm | S |
| 2026-09-29 | Body weight | 61.2 | kg | S |
| 2026-09-29 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 2026-09-29 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-09-29 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-09-29 | Heart rate | 72 | /min | S |
| 2026-09-29 | Respiratory rate | 14 | /min | S |
| 2026-09-29 | Body temperature | 36.8 | Cel | S |
| 2026-09-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-27 | Body height | 163 | cm | S |
| 2026-10-27 | Body weight | 61 | kg | S |
| 2026-10-27 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 2026-10-27 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-10-27 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-27 | Heart rate | 68 | /min | S |
| 2026-10-27 | Respiratory rate | 14 | /min | S |
| 2026-10-27 | Body temperature | 36.6 | Cel | S |
| 2026-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-13 | Body height | 163 | cm | S |
| 2026-10-13 | Body weight | 61 | kg | S |
| 2026-10-13 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 2026-10-13 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-10-13 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-13 | Heart rate | 70 | /min | S |
| 2026-10-13 | Respiratory rate | 14 | /min | S |
| 2026-10-13 | Body temperature | 36.7 | Cel | S |
| 2026-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-22 | Body height | 163 | cm | S |
| 2026-10-22 | Body weight | 61.1 | kg | S |
| 2026-10-22 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 2026-10-22 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-10-22 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-22 | Heart rate | 78 | /min | S |
| 2026-10-22 | Respiratory rate | 16 | /min | S |
| 2026-10-22 | Body temperature | 37.2 | Cel | S |
| 2026-10-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-09-15 | New patient visit for swelling of the face and legs and dark urine after a sore throat: urgent kidney and streptococcal tests, treatment of fluid overload and the infection, and an urgent nephrology referral | finished | S |
| 2026-09-17 | Two-day follow-up and nephrology consultation with ECG and echocardiogram | finished | S |
| 2026-09-29 | Two-week review: fluid, blood pressure, kidney function and C3; stop the diuretic | finished | S |
| 2026-10-27 | Six-week review: C3, kidney function, urine protein and blood, and the long-term plan | finished | S |
| 2026-10-13 | Periodic adult preventive visit | finished | S |
| 2026-10-22 | Same-day sick visit for a cold | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Urgent nephrology consultation within days for an acute nephritic syndrome with hypertension and a rise in creatinine: confirm the cause, decide whether a kidney biopsy is needed, and advise on fluid and blood pressure | completed | GL-KDIGO-GN-2021, GL-CMID-2026 | S |
| Sodium below 2 g a day, fluids limited to about 1.5 liters a day while swollen, and daily morning weights, with a call if weight rises 1 kg in a day, urine output falls, or headache, vision change, or breathlessness appear | completed | GL-KDIGO-GN-2021, GL-CMID-2026 | S |
| Furosemide each morning for edema and hypertension until he is back to his usual weight with normal blood pressure, with potassium and creatinine checked at each visit | completed | GL-KDIGO-GN-2021, GL-CMID-2026 | S |
| Penicillin V for ten days to eradicate group A streptococcus | completed | GL-IDSA-GAS-2012, GL-KDIGO-GN-2021 | S |
| Stop ibuprofen and avoid all NSAIDs while the kidneys recover; acetaminophen for pain | completed | GL-CMID-2026 | S |
| Assessment for acute rheumatic fever against the 2015 revised Jones criteria, with an ECG and an echocardiogram at the consultation; secondary prophylaxis only if the criteria are met | completed | GL-AHA-JONES-2015 | S |
| Monitoring until recovery: creatinine and potassium at each visit, C3 at two and six to eight weeks, urinalysis and urine protein-to-creatinine ratio at six weeks, six months, and a year, and blood pressure every year after; a kidney biopsy only if C3 stays low beyond eight weeks, creatinine keeps rising, nephrotic-range proteinuria persists, or the course is otherwise atypical | completed | GL-KDIGO-GN-2021, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Swelling gone and back to his usual weight of about 61 kg within two weeks | 2026-09-29 | completed | 61.2 kg with no edema at two weeks | S |
| Blood pressure below 130/80 mmHg with no blood pressure medicine needed by six weeks | 2026-10-27 | completed | 116/74 off all medicines at six weeks; the diuretic was stopped at two weeks | S |
| Creatinine back to normal by six weeks | 2026-10-27 | completed | 0.92 mg/dL at six weeks, from a peak of 1.78 | S |
| C3 back to normal within eight weeks | 2026-10-27 | completed | 108 mg/dL at six weeks | S |
| Urine protein-to-creatinine ratio below 150 mg/g | 2026-10-27 | active | Not yet met: 180 mg/g at six weeks, from 1400; recheck at six months | S |